Ann: US FDA Grants Approval for APAS-LBT.AX, page-703

TJ

I had the same concerns

try and keep it short and sweet

Main difference here is WASP captures an image that still needs a person to analyse on screen as it captures image from the automated process.

APAS software is the first Tech to do does the analysis - negative, positive, further investigation. eliminating the negative time save about 60% of a Bio time.

Bio And Coplan I think they are working on some sort of similar idea but not sure where they are up to.

4 Main players ( Not sure of Market share )here and which is why I believe we will see a different partner other than Bio. This is where I believe any partner will want shares rather than pay a upfront. At least they get a rebate via a dividend lol...

First mover advantage (FDA Approved) and cost are the other factors.

I have had limited discussions with management and perhaps some experts can help you out further.

Cheers